International Business News - Squibb http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Bristol-Myers Squibb Co. and AstraZeneca PLC said Monday that their drug candidate Onglyza reached its goals in two clinical trials, reducing the blood sugar levels of patients with type 2 diabetes. http://www.ibtimes.com/articles/20080908/bristol-myers-and-astrazeneca-report-onglyza-data.htm Mon, 08 Sep 2008 12:58:19 EDT Shares of Bristol-Myers Squibb Co. dipped Wednesday after the drug developer said its developing blood thinner apixaban failed in a late-stage study. The stock fell 46 cents, or 2.1 percent, to $21.52. Shares have traded between $19.43 and $30.35 over the last 52 weeks. http://www.ibtimes.com/articles/20080827/bristol-myers-shares-dip-on-failed-drug-study.htm Wed, 27 Aug 2008 17:18:43 EDT Among the earnings stories for Thursday, July 24, from AP Financial News: Top stories: http://www.ibtimes.com/articles/20080724/earnings-roundup-bristol-myers-squibb-3m.htm Thu, 24 Jul 2008 10:55:48 EDT The Massachusetts Medicaid program will receive more than $9 million as part of a settlement with Bristol-Myers Squibb to settle allegations of improper drug marketing and price reporting practices. http://www.ibtimes.com/articles/20080715/mass-to-get-9-2m-from-drug-marketing-settlement.htm Tue, 15 Jul 2008 13:50:27 EDT Bristol-Myers Squibb completed its $234.6 million acquisition of Kosan Biosciences, the company said late Thursday. Excluding Kosan's cash balance, Bristol is paying about $190 million in cash for the company. Bristol previously said it is financing the deal with cash on hand. http://www.ibtimes.com/articles/20080627/bristol-myers-squibb-completes-kosan-acquisition.htm Fri, 27 Jun 2008 09:14:12 EDT Biopharmaceutical company Bristol-Myers Squibb Co. said Wednesday the Hart-Scott-Rodino review period for its tender offer for cancer therapy maker Kosan Biosciences Inc. has expired. http://www.ibtimes.com/articles/20080618/bristol-myers-review-period-ends-for-kosan-deal.htm Wed, 18 Jun 2008 08:42:17 EDT Biopharmaceutical company Bristol-Myers Squibb Co. said Thursday that according to a study, patients given its drug Orencia to treat a type of arthritic pain over three years did not see a worsening of the disease. http://www.ibtimes.com/articles/20080612/bristol-myers-says-drug-blocks-spread-of-arthritis.htm Thu, 12 Jun 2008 09:05:52 EDT Shares of Bristol-Myers Squibb Co. sank to their lowest level in almost six years Tuesday as analysts expressed concerns with side effects associated with the two of the company's experimental diabetes drugs. http://www.ibtimes.com/articles/20080610/bristol-shares-hit-6-year-low-on-diabetes-data.htm Tue, 10 Jun 2008 17:08:14 EDT